DuPont de Nemours shares rose after Q2 2026 earnings beat consensus with $1.88 EPS and 4% revenue growth. Positive dividend signals and analyst outlook drove investor confidence despite cyclical marke
DuPont stock is recommended for its focus on innovation and acquisitions in healthcare and water, despite challenges from construction demand and rising oil and gas input costs.
Corient Private Wealth LP reduced its stake in DuPont de Nemours by 66.8% in Q2 2026, despite the company reporting strong earnings of $1.88 EPS and announcing a $0.60 quarterly dividend.
DuPont de Nemours has launched Tyvek with Renewable Attribution, offering 30%–100% renewable content certified by ISCC PLUS. This drop-in solution supports customer ESG targets with up to 30% CO2 redu
Allworth Financial LP cut its DuPont de Nemours stake by 68.6% in Q2 to hold $789,000 worth of shares. Despite this reduction, other institutions increased positions, and analysts maintain a Moderate
Engineers Gate Manager LP reduced its DuPont stake by 55.6% in Q2, selling 35,053 shares. DuPont reported strong Q2 earnings of $1.88 per share, exceeding estimates with 4% revenue growth.
Chemours, DuPont, and Corteva agreed to a $455 million settlement with North Carolina communities regarding PFAS contamination leaks from Chemours' Fayetteville facility. Payments will be distributed
Sequoia Financial Advisors LLC reduced its DuPont stake by 64.2% to $45.07 million in Q2. DuPont reported strong quarterly earnings beating estimates, with analysts maintaining a Moderate Buy rating.
CalSTRS increased its DuPont de Nemours stake to 38 million shares valued at $5.24 billion in Q2, indicating strong institutional interest despite recent trading declines.
IFP Advisors Inc increased its stake in DuPont de Nemours by 28.2% in Q2, acquiring 26,882 shares valued at $16.6 million amid the company's strong quarterly earnings report.
Groupe La Française acquired 10,271 shares of DuPont de Nemours worth approximately $1.39 million in Q2, while analysts maintain a Moderate Buy rating with a $166.60 price target.
Allianz reduced its DuPont stake by 48% to $14.15 million, though other investors increased positions. DuPont beat earnings estimates and announced a $0.60 quarterly dividend.
Bank OZK reduced its stake in DuPont de Nemours by 64.6% in Q2, selling 19,727 shares. DuPont also reported strong quarterly earnings beating estimates and declared a $0.60 dividend.
Nykredit A/S invested $5.66 million in DuPont de Nemours, acquiring 41,702 shares in Q2, amidst broader institutional interest despite recent dividend cuts.
Ancora Advisors LLC reduced its stake in DuPont de Nemours by 66.6% in Q2, selling 122,220 shares. DuPont reported strong Q2 earnings of $1.88 per share, beating estimates with 4% revenue growth.
Ballast Inc. reduced its stake in DuPont de Nemours by 55.9% in Q2, selling 15,628 shares. DuPont reported strong quarterly earnings, beating estimates with $1.88 EPS and a 4% revenue increase.
The New Mexico Educational Retirement Board reduced its DuPont stake by 64.6% in Q2, while institutional ownership remains near 74%. DuPont exceeded earnings expectations with analysts maintaining a M
The Public Employees Retirement System of Ohio acquired 81,458 shares of DuPont de Nemours valued at $11.05 million. The company also reported strong quarterly earnings exceeding analyst estimates.
Clifford Swan Investment Counsel LLC cut its DuPont position by 68.3% to $8.7 million in Q2. DuPont reported strong quarterly earnings of $1.88 EPS and 4% revenue growth, maintaining a Moderate Buy ra
DuPont de Nemours received a "Moderate Buy" consensus from 17 brokerages with an average price target of $166.60. The company reported strong Q2 earnings beating estimates and announced a quarterly di
Ancora Advisors LLC purchased 61,316 shares of DuPont de Nemours valued at approximately $8.3 million in Q2, while analysts maintain a Moderate Buy consensus with a price target of $166.60.
Cullen Capital Management initiated a $2.08 million position in DuPont de Nemours during Q2. The company reported strong second-quarter earnings, beating estimates with $1.88 EPS and declaring a $0.60
DuPont stock remains stable ahead of earnings, navigating a $2.5 billion PFAS settlement and legal developments. The company focuses on advanced materials for automotive and electronics while managing
DuPont de Nemours Inc. shares advanced 1.50% to $146.26, outperforming the broader market and breaking a two-day losing streak during a session where major indices declined.
DuPont de Nemours Inc. disclosed its asset turnover metric on the Buenos Aires Stock Exchange (BCBA:DD.CI). This financial data point tracks the company's operational efficiency.
DuPont de Nemours filed a Form S-4 effective August 11, 2026, signaling potential corporate restructuring. The filing carries neutral sentiment with standard stock data updates included.
Shares of DuPont de Nemours Inc. rose 2.08% to $144.49, outperforming the broader market and ending a three-day losing streak.
DuPont VP Madeleine Barber had 100.8 shares withheld on August 6, 2026, to cover tax liabilities on RSUs. The transaction was valued at $146.375 per share.
DuPont de Nemours received a "Moderate Buy" consensus from 17 research firms with a $165.40 price target. The company recently reported strong quarterly earnings that beat estimates and announced a $0
DuPont de Nemours Inc. shares rose 3.11% to $147.37, outperforming the broader market for the third consecutive day amid mixed trading conditions.
Shares of DuPont de Nemours Inc. rose 1.17% to close at $142.93 on Tuesday, marking two consecutive days of gains despite underperforming the broader S&P 500 and Dow Jones indices.
DuPont de Nemours reported a strong quarter exceeding Wall Street expectations, although its stock declined in early trading. The company had previously risen 17% year-to-date and 59% over the past 12
DuPont de Nemours Inc reported its revenue breakdown, with the United States contributing the largest share over the past two years. Segment and regional performance data are available on TradingView.
DuPont de Nemours identified the United States as its largest revenue contributor, generating $2.74 billion USD last year. This financial breakdown highlights regional performance based on data availa
DuPont de Nemours Inc. reported the United States as its largest revenue contributor, accounting for $2.74 billion last year. This figure represents a decrease from the previous year's $3.64 billion a
Texas Attorney General Ken Paxton leads a coalition of Republican attorneys general supporting a lawsuit against Chemours and DuPont regarding PFAS contamination. The case addresses states' authority
DuPont de Nemours Inc. stock rose 1.64% to $139.96, outperforming competitors amid broader market gains.
DuPont stock holds steady after fiscal 2025 reported net sales of $8.4 billion and adjusted EPS exceeding $3. A stable outlook is supported by its specialty materials portfolio and cost efficiency ini
DuPont de Nemours shares surpassed their 200-day moving average, accompanied by mixed analyst ratings averaging a 'Moderate Buy' and a $165.33 target price. The company also announced a quarterly divi
DuPont de Nemours Inc. shares rose 2.24% to $138.79, marking three consecutive days of gains and outperforming the broader market indices like the S&P 500 and Dow Jones Industrial Average.
DuPont's stock remains steady as investors assess its latest earnings alongside strong demand for specialty materials. The company is shifting towards higher-margin offerings in electronics and indust
DuPont's stock remains steady following strong earnings and strategic portfolio adjustments focused on performance materials and electronics. The company reported multi-billion dollar revenues support
Featuring DuPont De Nemours Inc, the global PPE market is projected to reach $877.84 billion by 2031 with a CAGR of 6.54%, driven by safety regulations and smart technology adoption.
DuPont has launched over 20 direct lithium extraction products to meet growing electric vehicle and energy storage demand. The new technologies offer faster lithium recovery from brines with potential
DuPont de Nemours received a consensus Moderate Buy rating from 17 analysts with an average price target of $165.33. The company beat Q1 2026 earnings estimates and announced a quarterly dividend.
Citigroup maintained its Buy rating on DuPont and raised the price target to $170, while independent analysis suggests the stock remains significantly overvalued.
DuPont de Nemours Inc. operating cash flow data is displayed on the Lang & Schwarz Exchange via TradingView, reflecting financial performance metrics.
TradingView displays net income data for DuPont de Nemours, Inc., noting the stock market is currently closed with no trades.
DuPont de Nemours Inc reported earnings of 1.43 EUR per share, exceeding estimates by 12.69%, with revenue at 1.45 billion EUR. Analysts forecast higher figures for the next quarter.
The GETTEX exchange lists net income information for DuPont de Nemours Inc, highlighting period, value, and change metrics provided by ICE Data Services and FactSet.
ChemBrief